Ellicott City, M.D., June 23, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year partnership with Laboratory Corporation of America® Holdings (LabCorp®) (LH: NYSE). Under the agreement, Covance Drug Development (Covance) will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.
“Covance’s commitment to partner with SCRS as a GIP demonstrates that establishing positive site relationships is a high priority for them,” commented Christine Pierre, SCRS President. “SCRS’ GIPs are focused on acknowledging the realities that today’s sites face, and actively addressing their challenges. SCRS is proud to welcome Covance as our newest Global Impact Partner.”
“Covance is committed to serving the clinical research community as a strong scientific partner in order to speed the development of innovative medicines that meet today’s global healthcare needs,” said Jill Johnston, Global Vice President, Site Activation, Informatics and Optimization, Covance. “Our work with SCRS will help us better understand the needs of our clinical research partners and ultimately improve service to our pharmaceutical and biotechnology clients.”
As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.